Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A papillary carcinoma that involves the body of uterus.
Biomarker and diagnostic research for papillary carcinoma of the corpus uteri has been reported in the published literature.
No clinical trials have been registered for papillary carcinoma of the corpus uteri.
13 publications have been identified in PubMed for papillary carcinoma of the corpus uteri. Research spans Diagnostic / Biomarker (31%), Case Report / Case Series (31%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 4 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
4 |
31% |
Disease patterns and progression | 2 | 15% |
Other research | 1 | 8% |
Research summaries | 1 | 8% |
Clinical study results | 1 | 8% |
Wei LL (2026). [PMID: 42245742](https://pubmed.ncbi.nlm.nih.gov/42245742/). *Front Oncol*. [Case Report / Case Series]
Li NM (2026). [PMID: 41644842](https://pubmed.ncbi.nlm.nih.gov/41644842/). *Discover oncology*. [Diagnostic / Biomarker]
Hu AJ (2025). [PMID: 41355113](https://pubmed.ncbi.nlm.nih.gov/41355113/). *Zhonghua bing li xue za zhi = Chinese journal of pathology*. [Diagnostic / Biomarker]
De Wispelaere N (2025). [PMID: 39854331](https://pubmed.ncbi.nlm.nih.gov/39854331/). *PloS one*. [Other]
Zhou Q (2025). [PMID: 40629663](https://pubmed.ncbi.nlm.nih.gov/40629663/). *Medicine*. [Review / Meta-Analysis]
Tabuchi K (2025). [PMID: 40115682](https://pubmed.ncbi.nlm.nih.gov/40115682/). *Cureus*. [Case Report / Case Series]
Wang C (2025). [PMID: 40469174](https://pubmed.ncbi.nlm.nih.gov/40469174/). *Frontiers in oncology*. [Diagnostic / Biomarker]
Gatta G (2025). [PMID: 40180806](https://pubmed.ncbi.nlm.nih.gov/40180806/). *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology*. [Epidemiology / Natural History]
Lambert K (2025). [PMID: 41050424](https://pubmed.ncbi.nlm.nih.gov/41050424/). *Gynecologic oncology reports*. [Case Report / Case Series]
Ryu SY (2025). [PMID: 40947016](https://pubmed.ncbi.nlm.nih.gov/40947016/). *Annals of oncology : official journal of the European Society for Medical Oncology*. [Clinical Trial Publication]